HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical aspects and therapy of early lepromatous leprosy with a case example].

Abstract
Taking into account the increase in worldwide human migration, leprosy is of growing importance in the differential diagnosis of dermatological diseases encountered in Central Europe. We report on the case of a young man from Ghana who developed hypopigmented maculae and plaques on his trunk and proximal limbs. The diagnosis of lepromatous leprosy could be made in consideration of the histological pattern of infiltrating leucocytes and detection of numerous acid-fast mycobacteria on skin biopsy. The results of the physical examination as well as routine laboratory and immunological parameters were consistent with this form of leprosy. Due to glucose-6-phosphate-dehydrogenase deficiency, treatment with dapsone was contraindicated. With high-dose rifampicin and clofazimine therapy, the skin changes cleared over the course of 11 months following a leprosy reaction type II (erythema nodosum leprosum) that developed during a phase of discontinued therapy due to low patient compliance.
AuthorsD Becker, W Bräuninger
JournalDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete (Hautarzt) Vol. 45 Issue 12 Pg. 845-8 (Dec 1994) ISSN: 0017-8470 [Print] Germany
Vernacular TitleKlinik und Therapie der frühen lepromatösen Lepra an einem Fallbeispiel.
PMID7843963 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Clofazimine
  • Rifampin
Topics
  • Adult
  • Biopsy
  • Clofazimine (administration & dosage)
  • Diagnosis, Differential
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Ghana
  • Humans
  • Leprosy, Lepromatous (diagnosis, drug therapy, pathology)
  • Leukocytes (pathology)
  • Long-Term Care
  • Male
  • Mycobacterium leprae (ultrastructure)
  • Rifampin (administration & dosage)
  • Skin (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: